Cristina W Nogueira Selected Research

Pilocarpine (Ocusert)

11/2010	Anticonvulsant effect of (E)-2-benzylidene-4-phenyl-1,3-diselenole in a pilocarpine model in mice.
6/2009	Anticonvulsant and antioxidant effects of 3-alkynyl selenophene in 21-day-old rats on pilocarpine model of seizures.
3/2008	Neuroprotective effect caused by MPEP, an antagonist of metabotropic glutamate receptor mGluR5, on seizures induced by pilocarpine in 21-day-old rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cristina W Nogueira Research Topics

Disease

13	Body Weight (Weight, Body) 01/2019 - 11/2004
10	Seizures (Absence Seizure) 08/2012 - 08/2003
8	Pain (Aches) 07/2015 - 02/2006
5	Inflammation (Inflammations) 07/2020 - 02/2007
4	Neoplasms (Cancer) 10/2020 - 11/2004
4	Obesity 01/2019 - 01/2016
4	Mitochondrial Diseases (Mitochondrial Disease) 12/2017 - 09/2010
4	Hyperalgesia 08/2017 - 10/2007
4	Memory Disorders (Memory Loss) 01/2017 - 06/2013
4	Cognitive Dysfunction 09/2013 - 02/2012
3	Hyperglycemia 01/2019 - 05/2012
3	Infections 01/2017 - 09/2013
3	Hemolysis 06/2015 - 01/2005
3	Malnutrition (Nutritional Deficiencies) 07/2008 - 06/2002
2	Metabolic Diseases (Metabolic Disease) 09/2021 - 01/2019
2	Amnesia (Dissociative Amnesia) 02/2020 - 01/2018
2	Mood Disorders (Mood Disorder) 01/2020 - 01/2017
2	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2019 - 12/2017
2	Insulin Resistance 01/2019 - 08/2018
2	Neuroinflammatory Diseases 05/2018 - 01/2017
2	Huntington Disease (Huntington's Disease) 09/2014 - 04/2013
2	Renal Insufficiency (Renal Failure) 01/2014 - 05/2011
2	Acute Kidney Injury (Acute Renal Failure) 01/2014 - 10/2009
2	Ischemia 10/2012 - 02/2005
2	Neuralgia (Stump Neuralgia) 12/2010 - 10/2007
2	Acidosis 07/2009 - 03/2009
2	Tardive Dyskinesia 07/2005 - 02/2003
2	Dyskinesias (Dyskinesia) 07/2005 - 02/2003
1	Weight Gain 01/2022
1	Substance-Related Disorders (Drug Abuse) 01/2022
1	Gliosis 05/2019
1	Wounds and Injuries (Trauma) 05/2019
1	Dyslipidemias (Dyslipidemia) 01/2019

Drug/Important Bio-Agent (IBA)

18	diphenyldiselenideIBA 05/2018 - 01/2007
11	Proteins (Proteins, Gene)FDA Link 07/2020 - 06/2002
8	Glutamic Acid (Glutamate)FDA Link 09/2013 - 08/2003
7	AntioxidantsIBA 01/2017 - 03/2009
5	Sodium Glutamate (Accent)IBA 01/2019 - 07/2015
5	ebselenIBA 01/2018 - 02/2003
4	p-chloro-diphenyl diselenideIBA 08/2018 - 06/2012
4	SeleniumIBA 01/2017 - 01/2016
4	Thiobarbituric Acid Reactive SubstancesIBA 02/2007 - 02/2003
3	Scopolamine (Hyoscine)FDA Link 02/2020 - 08/2013
3	AcetylcholinesteraseIBA 02/2020 - 09/2013
3	Antidepressive Agents (Antidepressants)IBA 01/2020 - 12/2010
3	Opioid Analgesics (Opioids)IBA 01/2020 - 12/2008
3	CatalaseIBA 08/2011 - 05/2007
3	Pentylenetetrazole (Metrazol)IBA 11/2010 - 06/2009
3	Pilocarpine (Ocusert)FDA LinkGeneric 11/2010 - 03/2008
3	Sulfhydryl Compounds (Thiols)IBA 09/2010 - 01/2005
3	Acetic Acid (Vinegar)FDA LinkGeneric 06/2009 - 02/2006
2	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 01/2014
2	Cholinergic Agents (Cholinergics)IBA 02/2020 - 03/2008
2	m-trifluoromethyl-diphenyl diselenideIBA 01/2020 - 11/2009
2	GuanosineIBA 05/2019 - 12/2017
2	Insulin (Novolin)FDA Link 01/2019 - 05/2012
2	EnzymesIBA 08/2018 - 05/2007
2	bis(phenylimidazoselenazolyl) diselenideIBA 08/2017 - 02/2013
2	Antiviral Agents (Antivirals)IBA 01/2017 - 01/2016
2	LipopolysaccharidesIBA 01/2017 - 05/2009
2	Adenosine Diphosphate (ADP)IBA 01/2017 - 01/2016
2	Adenosine Triphosphate (ATP)IBA 01/2016 - 09/2014
2	CytokinesIBA 01/2015 - 10/2012
2	3-nitropropionic acidIBA 09/2014 - 04/2013
2	CreatinineIBA 01/2014 - 05/2011
2	Urea (Carbamide)FDA LinkGeneric 01/2014 - 05/2011
2	Adenosine Triphosphatases (ATPase)IBA 09/2013 - 06/2008
2	Therapeutic UsesIBA 06/2013 - 11/2004
2	Kainic Acid (Kainate)IBA 08/2012 - 06/2009
2	AcidsIBA 08/2011 - 11/2010
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 08/2011 - 06/2008
2	Glycerol (Glycerine)FDA LinkGeneric 05/2011 - 10/2009
2	Analgesics (Analgesic Drugs)IBA 12/2010 - 12/2008
2	Anticonvulsants (Antiepileptic Drugs)IBA 11/2010 - 06/2009
2	DABAIBA 11/2010 - 11/2009
2	gamma-Aminobutyric Acid (GABA)IBA 11/2010 - 11/2009
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 05/2009 - 03/2008
2	N-Methylaspartate (NMDA)IBA 06/2008 - 10/2007
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2008 - 12/2005
2	Indicators and Reagents (Reagents)IBA 01/2008 - 05/2007
2	BradykininIBA 10/2007 - 01/2007
2	Free RadicalsIBA 05/2007 - 07/2005
2	thiobarbituric acidIBA 02/2007 - 01/2005
2	Capsaicin (Zostrix)FDA Link 01/2007 - 02/2006
1	Pharmaceutical PreparationsIBA 01/2022
1	Morphine (MS Contin)FDA LinkGeneric 01/2022
1	Streptozocin (Streptozotocin)FDA Link 09/2021
1	Antineoplastic Agents (Antineoplastics)IBA 10/2020
1	Muscarinic M1 ReceptorIBA 02/2020
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2019
1	cresyl violetIBA 05/2019
1	SynaptophysinIBA 05/2019
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Tyrosine Transaminase (Tyrosine Aminotransferase)IBA 01/2019
1	LipidsIBA 08/2018
1	CarbohydratesIBA 08/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	NucleosidesIBA 12/2017

Therapy/Procedure

1	Resistance Training 01/2019